Does ischaemic pre-conditioning reduce renal damage during elective infra-renal aortic aneurysm repair? Randomised controlled trial.
| ISRCTN | ISRCTN89918035 | 
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN89918035 | 
| Secondary identifying numbers | 05/Q0108/276 - NRR ref N0544174223 | 
- Submission date
 - 02/11/2005
 - Registration date
 - 15/11/2005
 - Last edited
 - 16/12/2010
 
- Recruitment status
 - No longer recruiting
 - Overall study status
 - Completed
 - Condition category
 - Circulatory System
 
            
            Prospectively registered
        
    
                    
                        
    
        
            
            Protocol
        
    
                    
                        
    
        
            
            Statistical analysis plan
        
    
                    
                        
    
        
            
            Results
        
    
                    
                        
    
        
            
            Individual participant data
        
    
                    
                        
    
                    
                    Plain English summary of protocol
Not provided at time of registration
Contact information
                                            Mr Michael Gaunt
Scientific
                                        Scientific
                                                Consultant Vascular Surgeon
Cambridge Vascular Unit
Box 201 Level 7
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 2QQ
United Kingdom
                                                
| Phone | +44 (0)1223 216992 | 
|---|---|
| michael.gaunt@addenbrookes.nhs.uk | 
Study information
| Study design | Randomised controlled trial | 
|---|---|
| Primary study design | Interventional | 
| Secondary study design | Randomised controlled trial | 
| Study setting(s) | Hospital | 
| Study type | Not Specified | 
| Scientific title | |
| Study objectives | Ischaemic preconditioning during open infra-renal aortic aneurysm repair will reduce intra-operative renal damage. | 
| Ethics approval(s) | The trial has been reviewed and approved by the Cambridgeshire Research Ethics Committee, October 2005. REC reference number 05/Q0108/276. | 
| Health condition(s) or problem(s) studied | Abdominal aortic aneurysm | 
| Intervention | Participants will be randomised to undergo clamping or not. The intervention consists of application of a crossclamp to each common iliac artery for 10 minutes followed by 10 minutes reperfusion time during the dissection phase of the operation. Each common iliac artery will be clamped in sequence not simultaneously. The temporary interruption to blood flow in the leg provides an ischaemic stimulus that appears to protect the heart from damage during the operation. This trial aims to determine if the same technique protects the kidneys. | 
| Intervention type | Other | 
| Primary outcome measure | 1. Post-operative urinary albumin-creatinine ratios 2. Post-operative creatinine clearance 3. Post-operative glomerular filtration rate  | 
| Secondary outcome measures | No secondary outcome measures | 
| Overall study start date | 14/11/2005 | 
| Completion date | 14/11/2006 | 
Eligibility
| Participant type(s) | Patient | 
|---|---|
| Age group | Adult | 
| Sex | All | 
| Target number of participants | 40 | 
| Key inclusion criteria | Patients undergoing elective open repair of an infra-renal abdominal aortic aneurysm. | 
| Key exclusion criteria | 1. Pre-existing renal failure 2. Baseline serum creatinine >150 µmols/l 3. Baseline serum urea >20 mmols/l 4. Previous history of acute renal failure 5. Previous renal transplant 6. Previous renal disease 7. Previous endovascular aneurysm repair 8. Previous renal replacement therapy 9. Suprarenal aneurysm 10. Ankle-brachial pressure index <0.7  | 
| Date of first enrolment | 14/11/2005 | 
| Date of final enrolment | 14/11/2006 | 
Locations
Countries of recruitment
- England
 - United Kingdom
 
Study participating centre
                                            Consultant Vascular Surgeon
                                        
                                        
                                            
                                            Cambridge
CB2 2QQ
United Kingdom
                                    CB2 2QQ
United Kingdom
Sponsor information
                                            Cambridge University Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre
                                        Hospital/treatment centre
                                                Dr John Bradley
Director of R&D
R&D Office
Box 146
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 2QQ
England
United Kingdom
                                                
| Phone | +44 (0)1223 274486 | 
|---|---|
| joanne.heritage@addenbrookes.nhs.uk | |
| Website | http://www.addenbrookes.nhs.uk/research | 
| https://ror.org/04v54gj93 | 
Funders
Funder type
Hospital/treatment centre
                                                Cambridge Vascular Unit's own in-house research fund. This is not a trust own account or an NHS R&D funded project.
                                            
                                            No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No | 
| IPD sharing plan summary | Not provided at time of registration | 
| Publication and dissemination plan | Not provided at time of registration | 
| IPD sharing plan | 
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? | 
|---|---|---|---|---|---|
| Results article | results | 01/07/2010 | Yes | No |